Authors | Name of questionnaire | Psychometric evaluation(s) | Time of administration | Target population | Study population | Mode of administration |
---|---|---|---|---|---|---|

Kirmit et al57 | AAOS-HS | Inter-tester reliability | Preop. | Hip OA | N=35 (IA) | Observer-administered |

18♀, 17♂ | ||||||

Mean (SD) 58.8 (2.2) y | ||||||

Range (28–76 y) | ||||||

Martin et al38 | HOS | Content validity | Clinical visit/Postop. | Labral tear/hip arthroscopy | N=507 (IA) | Self-administered |

Internal consistency | 273♀, 232♂ | |||||

Construct validity | Mean (SD) 38 (13) y | |||||

Range (13–66 y) | ||||||

Martin et al42 | HOS | Construct validity | Postop. | Hip arthroscopy | N=107 (IA) | Self-administered |

56♀, 51♂ | ||||||

Mean (SD) 42 (14) y | ||||||

Range (14–79) y | ||||||

Martin et al52 | HOS | Test–retest reliability | Preop./Postop. | Hip arthroscopy | N=126 (IA) | Self-administered |

Responsiveness | 59♀, 67♂ | |||||

Mean (SD) 41 (16) y | ||||||

Range (13–80) y | ||||||

Klassbo et al35 | HOOS | Content validity | Clinical visit | Hip OA | N=52 (IA) | Self-administered |

Internal consistency | 35♀, 17♂ | |||||

Construct validity | Median 64 y | |||||

Floor and ceiling effects | Range (42–84 y) | |||||

Test–retest reliability | ||||||

Agreement | ||||||

Nilsdotter et al41 | HOOS | Content validity | Preop./Postop. | THR | N=90 (ES) | Self-administered |

Internal consistency | 41♀, 49♂ | |||||

Construct validity | Mean 71.5 y | |||||

Floor and ceiling effects | Range (49–85 y) | |||||

Responsiveness | ||||||

Interpretability | ||||||

de Groot et al43 | HOOS | Internal consistency | Clinical visit/Postop. | Hip OA/THR | N=162 (IA) | Self-administered |

Construct validity | Range (31–88 y) | |||||

Floor and ceiling effects | ||||||

Test–retest reliability | ||||||

Agreement | ||||||

Responsiveness | ||||||

Interpretability | ||||||

Johanson et al53 | HRQ | Internal consistency | Preop./Postop. | THR | N=98 (ES) | Self-administered |

Construct validity | Follow-up: 3, 6, 12 months | 61♀, 37♂ | ||||

Test–retest reliability | Mean (SD) 65 (10) y | |||||

Agreement | Range (21–90) y | |||||

Responsiveness | 3 months N=98 | |||||

Interpretability | 6 months N=62 | |||||

12 months N=42 | ||||||

Franneby et al76 | IPQ | Internal consistency | Postop. | Open groin-hernia repair | N=200 (IA) | Self-administered |

Construct validity | 5%♀, 95%♂ | |||||

Test–retest reliability | Mean (SD) 63 (14) y | |||||

Lequesne et al77 | LISH | Inter-tester reliability | During clinical trial | Hip OA | N=38 (ES) | Observer-administered |

Stucki et al32 | LISH | Internal consistency | Clinical visit | Hip OA | N=22 (ES) | Self-administered |

Construct validity | ||||||

Test–retest | ||||||

Interpretability | ||||||

Stucki et al33^{*} | LISH | Internal consistency | Clinical visit | Hip OA | N=22 (ES) | Self-administered |

Construct validity | ||||||

Ludwig et al44 | LISH | Internal consistency | Preop./Postop. | THR | N=112 (ES) | Self-administered |

Construct validity | 39♀, 73♂ | |||||

Test–retest reliability | ||||||

Responsiveness | ||||||

Dawson et al40 | LISH | Content validity | Baseline | Unilateral hip pain | N=471 (IA) | Self-administered |

Internal consistency | Follow-up: 12 month | 60.5%♀, 39.5%♂ | ||||

Construct validity | Range (68–79 y) | |||||

Potter et al45 | MHHS | Construct validity | Postop. | Hip arthroscopy | N=33 (IA) | Observer-administered |

Interpretability | Mean follow-up: 25.7 months | 19♀, 14♂ | ||||

Mean 34.6 y | ||||||

Range (21–56) y | ||||||

Christensen et al36 | NHS | Content validity | Clinical visit | Hip pain for 6 months, no signs of radiographic OA | N=48 (IA) | Self-administered |

Internal consistency | 29♀, 19♂ | |||||

Construct validity | Mean 33 y | |||||

Test–retest reliability | Range (16–45 y) | |||||

Dawson et al29 | OHS | Content validity | Preop./Postop. | THR | N=220 (ES) | |

Internal consistency | 131♀, 89♂ | |||||

Construct validity | Median 70.5 y | |||||

Test–retest reliability | Range (35.8–89.6 y) | |||||

Responsiveness | ||||||

Interpretability | ||||||

Dawson et al30 | OHS | Responsiveness | Preop./Postop. | THR | N=186 (IA) | |

Interpretability | Follow-up: 6 months | 117♀, 69♂ | ||||

Median 70.5 y | ||||||

Mean (SD) 69.4 (3.5) y | ||||||

Range (37.5–89.6 y) | ||||||

Fitzpatrick et al31 | OHS | Responsiveness | Preop./Postop. | THR | N=186 (IA) | |

Interpretability | 63%♀, 37%♂ | |||||

Median age 70.5 y | ||||||

Mean (SD) 69.4 (3.5) y | ||||||

Range (37.5–89.6 y) | ||||||

Fitzpatrick et al78 | OHS | Internal consistency | Preop./Postop. | THR | N=7151 (ES) | |

Responsiveness | Follow-up: 3 and 12 months | 61.4%♀, 38.6%♂ | ||||

Interpretability | Mean (SD) 67.8 (10.9) y | |||||

3 months N=6174 | ||||||

12 months N=5854 | ||||||

Dawson et al79 | OHS | Construct validity | Preop./Postop. | THR | N=609 (ES) | |

Responsiveness | Follow-up: 1 y | |||||

Interpretability | ||||||

Ostendorf et al48^{*} | OHS | Responsiveness | Preop./Postop. | THR | N=114 (IA) | |

Construct validity | Follow-up: 3 months, 1 y | 62.3%♀, 37.7%♂ | ||||

Floor and ceiling effect | Mean (SD) 67.6 (10.1) y | |||||

Interpretability | Range (35.9–88.8 y) | |||||

Gosens et al54 | OHS | Content validity | Preop./Postop. | THR | N=150 (ES) | Self-administered |

Internal consistency | 98♀, 52♂ | |||||

Construct validity | Mean 65 y | |||||

Test–retest reliability | Range (38–85 y) | |||||

Responsiveness | ||||||

Interpretability | ||||||

Garbuz et al49^{*} | OHS | Construct validity | Preop./Postop. | THR | N=402 (IA) | Self-administered |

Floor and ceiling effects | Follow-up: 12 months | 53%♀, 47%♂ | ||||

Responsiveness | Mean 61 y | |||||

Naal et al46 | OHS | Internal consistency | Preop. | THR | N=105 (IA) | Self-administered |

Construct validity | 48♀, 57♂ | |||||

Floor and ceiling effect | Mean (SD) 63.4 (11) y | |||||

Test–retest reliability | Range (33–88 y) | |||||

Agreement | ||||||

Wright et al37 | PASI | Content validity | Preop. | THR | N=72 (IA) | Observer-administered |

49%♀, 51%♂ | ||||||

Mean (SD) 64 (7) y | ||||||

Range(17–92 y) | ||||||

Wright and Young27 | PASI | Construct validity | Preop./Postop. | THR | N=78 (IA) | Observer-administered |

Test–retest reliability | Follow-up: 6 months | 45%♀, 55%♂ | ||||

Inter-tester reliability | Mean 62.2 y | |||||

Responsiveness | Range (25–87 y) | |||||

Interpretability | ||||||

Wright and Young28^{*} | PASI | Construct validity | Preop./Postop. | THR | N=78 (IA) | Observer-administered |

Test–retest reliability | 45%♀, 55%♂ | |||||

Inter-tester reliability | Mean 62.2 y | |||||

Responsiveness | Range (25–87 y) | |||||

Wright et al55 | PASI | Construct validity | Preop./Postop. | THR | N=55 (IA) | Self-administered |

Test–retest reliability | 58%♀, 42%♂ | |||||

Mean 65.6 y | ||||||

Range (28–84 y) | ||||||

Whitehouse et al80 | R-WOMAC-FS | Internal consistency | Postop. | THR | N=716 (ES) | Self-administered |

Construct validity | Follow-up: 36 months | Mean (SD) 73.6 (5.5) y | ||||

Range (65–93 y) | ||||||

36 months N=665 | ||||||

Liang et al39^{†} and Katz et al81 | THAOQ | Content validity^{*} | Preop./Postop. | THR | N=54 (IA) | Self-administered |

Construct validity | 36♀, 18♂ | |||||

Test–retest reliability | Mean (SD) 60 (13) y | |||||

Range (25–82 y) | ||||||

Stucki et al34 | WOMAC | Construct validity | Clinical visit | Hip OA | N=22 (ES) | Self-administered |

Wright and Young28^{*} | WOMAC | Construct validity | Preop./Postop. | THR | N=78 (IA) | Observer-administered |

Test–retest reliability | Follow-up: 6 months | 45%♀, 55%♂ | ||||

Inter-tester reliability | Mean 62.2 y | |||||

Responsiveness | Range (25–87 y) | |||||

Interpretability | ||||||

Stucki et al33^{*} | WOMAC | Internal consistency | Clinical visit | Hip OA | N=22 (ES) | Self-administered |

Construct validity | ||||||

Söderman and Malchau50 | WOMAC | Internal concistency | Postop. | THR | N=58 (IA) | Self-administered |

Construct validity | Follow-up: 2–10 y | 38♀, 20♂ | ||||

Floor and ceiling effect | Mean 71 y | |||||

Test–retest reliability | Range (52–86 y) | |||||

Interpretability | ||||||

Angst et al82 | WOMAC | Responsiveness | Pre-/post treatment. | Hip OA | N=93 (IA) | Self-administered |

3–4 weeks rehabilitation | 66%♀, 34%♂ | |||||

Follow-up: 3 months | ||||||

Nilsdotter et al83 | WOMAC | Responsiveness | Postop. | THR | N=20 (IA) | Self-administered |

Follow-up: 3, 6 and 12 months | 13♀, 7♂ | |||||

Mean 72.6 y | ||||||

Range (52–86) y | ||||||

Escobar et al84 | WOMAC | Responsiveness | Preop./Postop. | THR | N=100 (IA) | Self-administered |

Interpretability | 56♀, 44♂ | |||||

Mean (SD) 68.6 (10.3) y | ||||||

Ostendorf et al48^{*} | WOMAC | Responsiveness | Preop./Postop. | THR | N=114 (IA) | Self-administered |

Construct validity | Follow-up: 3 months, 1 y | 62.3%♀, 37.7%♂ | ||||

Floor and ceiling effect | Mean (SD) 67.6 (10.1) y | |||||

Interpretability | Range (35.9–88.8 y) | |||||

Roorda et al47 | WOMAC | Internal consistency | Preop. | THR | N=180 (IA) | Self-administered |

Construct validity | 65%♀, 35%♂ | |||||

Test–retest reliability | Mean (SD) 67.9 (10.7) y | |||||

Interpretability | ||||||

Quintana et al51 | WOMAC | Internal consistency | Preop./Postop. | THR | 6 month: N=379 (IA) | Self-administered |

Floor and ceiling effect | Follow-up: 6 months, 2 y | 2 years: N=310 (IA) | ||||

Agreement | ||||||

Responsiveness | ||||||

Interpretability | ||||||

Garbuz et al49^{*} | WOMAC | Construct validity | Preop./Postop. | THR | N=402 (IA) | Self-administered |

Floor and ceiling effects | Follow-up: 12 months | 53%♀, 47%♂ | ||||

Responsiveness | Mean 61 y | |||||

SooHoo et al^{85} | WOMAC | Responsiveness | Preop./Postop. | THR | N=89 (ES) | Self-administered |

Interpretability | Follow-up: 5–43 months | 54%♀, 46%♂ | ||||

Mean 60 y | ||||||

Range (20–91 y) | ||||||

Soininen et al56 | WOMAC | Construct validity | Preop. /postop. | THR | N=33 (ES) | Self-administered |

Test–retest reliability | Follow-up: 3 months | |||||

Agreement | ||||||

Responsiveness | ||||||

Interpretability |

↵* Studies evaluating two questionnaires.

↵† Evaluating content validity of THAOQ including experts but not including any patients.

♀, female; ♂, male; AAOS-HS, American Academy of Orthopaedic Surgeons Hip Score; ES, enrolled in the study; HOOS, Hip dysfunction and Osteoarthritis Outcome Score; HOS, Hip Outcome Score; HRQ, Hip Rating Questionnaire; IA, included in the analysis; IPQ, Inguinal Pain Questionnaire; LISH, Lequesne Index of Severity for Osteoarthritis of the Hip; MHHS, Modified Harris Hip Score; NHS, Nonarthritic Hip Score; OA, osteoarthritis; OHS, Oxford Hip Score; PASI, Patient Specific Index; Preop., preoperative; Postop, postopertaive; R-WOMAC-FS, Reduced Western Ontario and McMaster Universities Osteoarthritis index Function Score; THAOQ, Total Hip Arthroplasty Outcome Questionnaire; THR, total hip replacement; y, years.